Atrivita ApS: Financial statements 2023
CVR: 42734233
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Atrivita ApS (CVR 42734233) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 606,915 and a net result of DKK 468,941. Equity in the 2023 report amounted to DKK 568,332. The solvency ratio was 36.2%.
- Gross Profit
- DKK 606,915
- Profit/Loss
- DKK 468,941
- Equity
- DKK 568,332
- Total Assets
- DKK 1,570,032
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 9, 2023, is registered as an owner of Atrivita ApS with an ownership share of 50%.
Atrivita ApS has published its interim report for the period September 28, 2021 to December 31, 2022.
About Atrivita ApS
Atrivita ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MedPro Health ApS. The management consists of Bo Tandrup. The board consists of Ivan Berkes (chair). The company is owned by COMMERCE PHARMA HOLDING ApS and London Pharma Capital Limited. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,618,949 and a net result of DKK 635,955 compared with DKK 290,857 the year before. Equity in the 2025 report amounted to DKK 1,495,144.